Results

Total Results: 398 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

  1. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/depression-in-children-and-adolescents-screening
    February 08, 2016 - In summary, the Patient Health Questionnaire for Adolescents and BDI reported the highest sensitivity … The patients eligible for these trials may not be representative of all patients with MDD seen in primary … Screening and treating depression: patient preferences and implications for social workers. … serotonin reuptake inhibitors in pediatric depression: did unpublished studies influence the efficacy/safety … disorders among adolescent primary care patients.
  2. www.uspreventiveservicestaskforce.org/home/getfilebytoken/yzXkWEQV3pn95yd_pmXZXk
    December 15, 2020 - Clinicians should understand the evidence but individualize decision-making to the specific patient or … Trials evaluated first-line therapies (ie, therapies with the highest proven efficacy and safety, including … Most studies ad- justed for patient age, sex, and stage of fibrosis; some also adjusted for level of … - penia or osteoporosis in patients treated with TDF or entecavir with patients receiving no therapy … Clinicians should understand the evidence but individualize decision-making to the specific patient or
  3. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/lipid-disorders-in-children-screening
    July 18, 2023 - unaffected siblings. 42 , 55 One compelling observation from a 20- year follow-up study of 214 treated patients … Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American … Safety of a fat-reduced diet: the Dietary Intervention Study in Children (DISC). … Statin initiation during childhood in patients with familial hypercholesterolemia: consequences for cardiovascular … ) No health outcomes Insufficient Low-intensity diet and physical activity intervention for patients
  4. www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction-2002
    July 08, 2002 - Clinicians should inform patients of the potential benefits and harms of chemoprevention. … some high-risk women but will depend on breast cancer risk, risk for potential harms, and individual patient … Clinicians can use this information to help individual patients considering tamoxifen therapy estimate … efficacy for breast cancer chemoprevention are under way, including a trial comparing efficacy and safety
  5. JAMA JATS (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/pKa4_DYwzuyD6RDgYzLMbo
    August 22, 2018 - 16):1688-1701. doi:10.1001/jama.2018.13212 Editorial page 1645 Related article page 1678 and JAMA Patient … questions, and received information about referral options Women with a positive response to safety … If questions indicated a safety concern, the emergency department provider was notified and a referral … Clinical utility of an intimate partner violence screening tool for female VHA patients. … Safety-promoting behaviors of community-dwelling abused Chinese women after an advocacy intervention:
  6. www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-prevent-neural-tube-defects-preventive-medication-1996
    January 01, 1996 - 105 Whether or not to receive MSAFP screening therefore depends on the preferences of the individual patient … Midtrimester amniocentesis for prenatal diagnosis: safety and accuracy. … The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities … Folic acid safety and toxicity: a brief review. Am J Clin Nutr . 1989;50:353–358. [ PubMed ] 94. … Safety of amniocentesis. Lancet . 1986;2:225–226. 106. National Center for Health Statistics.
  7. www.uspreventiveservicestaskforce.org/home/getfilebytoken/wKfFrTpC8VtforKLrqGpjQ
    April 18, 2023 - Studies of patient skin self-examination were excluded be- cause this topic is covered in the 2018 USPSTF … Overdiagnosis can result in overtreatment that may not benefit the patient.14 Data Extraction and Quality … questions (KQs) that the review will address to allow the USPSTF to evaluate the effectiveness and safety … Studies used large databases with patient information from the US (SEER [Surveillance, Epidemiology, … Effects of the German skin cancer screening programme on melanoma incidence and indicators of disease
  8. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication-november-2016
    November 13, 2016 - A meta-analysis of individual-patient data from 22 trials, including trials of patients with prior cardiovascular … We did not have access to individual-patient data. … Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type … The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety
  9. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/screening-anxiety-children-adolescents
    October 11, 2022 - Eligible harms of treatment included treatment avoidance, deterioration in patient-clinician relationship … The patient health questionnaire for adolescents: validation of an instrument for the assessment of mental … disorders among adolescent primary care patients. … Child/adolescent anxiety multimodal study: evaluating safety. … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety
  10. www.uspreventiveservicestaskforce.org/home/getfilebytoken/MnkNvteY4Yg_8Jut4SayVN
    July 02, 2002 - Clinicians should inform patients of the potential benefits and harms of chemoprevention. … some high-risk women but will depend on breast cancer risk, risk for potential harms, and individual patient … efficacy for breast cancer chemoprevention are under way, including a trial comparing efficacy and safety … The USPSTF recommends that clinicians routinely provide [the service] to eligible patients. … The USPSTF recommends against routinely providing [the service] to asymptomatic patients.
  11. www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-3-topic-work-plan-development
    June 22, 2025 - This definition acknowledges the importance of the patient clinician relationship as facilitated and … be answered by the literature review in order for the Task Force to evaluate the effectiveness and safety … Similarly, analytic frameworks do not guide clinical decisionmaking for an individual patient, nor do … A clinical "sign" is not a health outcome that is not sensed by the patient; a clinical sign is analogous … These are not direct measures of health but are indicators of positive or negative effects on the larger
  12. www.uspreventiveservicestaskforce.org/home/getfilebytoken/p6k4ooduXN8RQoVGS9H5Sx
    March 01, 2011 - (16):1599-1608. doi:10.1001/jama.2020.3332 Editorial page 1563 Related article page 1590 and JAMA Patient … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety … Another pharmacotherapy for smoking cessation is vareni- cline, which is not recommended for patients … Key Substance Use and Mental Health Indicators in the United States: Results from the 2018 National Survey … Efficacy and safety of varenicline for adolescent smoking cessation: a randomized clinical trial.
  13. www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-medications-for-risk-reduction
    September 03, 2019 - Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients … As with all of its recommendations, the USPSTF encourages clinicians to discuss with patients the risks … PDQ Breast Cancer Prevention (PDQ®)—Patient Version. NCI website. … Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation. … Safety assessment of raloxifene over eight years in a clinical trial setting.
  14. www.uspreventiveservicestaskforce.org/uspstf/recommendation/diet-behavioral-counseling-primary-care-adults-2003
    June 15, 2003 - (go to " Scientific Evidence " for discussion of patient populations and intensity of interventions) … disentangle the effects of patient risk status from the effects of intervention intensity. … Safety of a fat-reduced diet: the Dietary Intervention Study in Children (DISC). … Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein … How does physician advice influence patient behaviours? Arch Fam Med 2000;9:426-433.
  15. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan105/latent-tuberculosis-infection-screening-september-2016
    September 25, 2014 - The framework starts on the left with the patient population of interest, asymptomatic adults at increased … subspecialty clinics (e.g., oncology, rheumatology, dermatology, transplant) where TB screening in patients … employees for LTBI as part of a formal surveillance program for occupational exposure under Occupational Safety
  16. www.uspreventiveservicestaskforce.org/home/getfilebytoken/poDYcagnw7SqKNNbrFt_CV
    June 11, 2019 - Clinicians should understand the evidence but individualize decision making to the specific patient or … professional judgment and patient preferences. … Components of adherence support include establishing trust and open communication with patients, patient … Research is also needed on the long- term safety and effectiveness of PrEP. … An HIV preexposure prophylaxis demonstration project and safety study for young MSM.
  17. www.uspreventiveservicestaskforce.org/home/getfilebytoken/b5LjDb3-UoPV8LEWavJWB8
    February 01, 2010 - questions (KQs) (with 6 sub-KQs) and an analytic framework (Fig 1) to evaluate the effectiveness and safety … In the Maahs et al trial,36 1 suicide death of a patient who was under a psy- chiatrist’s care occurred … Note that 9% of or- listat patients reported fecal inconti- nence, compared with�1% of patients on placebo … been conducted among children aged �11 years, so no conclusions can be drawn regarding efficacy or safety … 2010 e415 APPENDIX 4 Evidence Table Template Study Reference, Study Quality Study Characteristics Patient
  18. www.uspreventiveservicestaskforce.org/home/getfilebytoken/rQBBkz9CrHh4vp7ZnEkF-t
    July 18, 2023 - -274. doi:10.1001/jama.2023.8867 Editorial page 225 Multimedia Related article page 253 and JAMA Patient … (12 wk) No health outcomes Insufficient Low-intensity diet and physical activity intervention for patients … unaffected siblings.42,55 One compelling ob- servation from a 20-year follow-up study of 214 treated patients … Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American … Statin initiation during childhood in patients with familial hypercholesterolemia: consequences for cardiovascular
  19. www.uspreventiveservicestaskforce.org/home/getfilebytoken/9H5mgkBCjNQVZZ4pnkNo6B
    February 01, 2016 - Synthesis: Limited evidence from 5 studies showed that such tools as the Beck Depression Inventory and Patient … These 5 studies ex- amined such instruments as the Patient Health Ques- tionnaire for Adolescents, Beck … In summary, the Patient Health Questionnaire for Adolescents and BDI reported the highest sensitivity … The patients eligible for these trials may not be representative of all patients with MDD seen in primary … serotonin reuptake inhibitors in pediatric depression: did unpublished studies influence the efficacy/safety
  20. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-screening-for-familial-hypercholesterolemia/lipid-disorders-in-children-screening-july-2016
    August 09, 2016 - Health outcomes (KQ1, KQ5, and KQ8) were defined as those experienced by the patient. … Participants in the included statin trials were patients at tertiary care centers; none of the studies … Further consideration of genetic mutation status in treatment response and outcomes for patients with … Mean % Change (SD) No. of Patients Mean % Change (SD) Pravastatin Knipscheer et al … a Studies included for KQ7 involved 2210 patients, 2197 of whom had FH.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: